Search

everythinglearnresearchcommunity

for

Search:↓

Severe alopecia areata in South Korea has a high treatment burden, with most patients needing multiple treatments and frequent doctor visits.

Tofacitinib is an effective and safe treatment for alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Belimumab may cause hair loss in lupus patients.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Higher inflammation markers are linked to more severe alopecia areata.

Talquetamab may cause hair loss and skin issues.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Vitamin D levels are not linked to Alopecia Areata.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

PRP is an effective and safe treatment for alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Antioxidants improved hair growth in alopecia areata patients regardless of disease duration.

Higher RBP4 levels found in people with two types of hair loss.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

People with Alopecia areata often have lower vitamin D levels, which may be linked to the severity of their condition.

Dermatoscopy can quickly help distinguish between alopecia areata and tinea capitis in children.

Zinc deficiency may contribute to alopecia areata and vitiligo.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Melatonin reduced oxidative stress and might improve hair growth in alopecia areata patients.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.